Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you have missed three weeks of Wegovy, the right step depends on which dose you are on and how long it has been since your last injection. Missing three weeks takes you beyond the standard guidance for simply resuming where you left off. The Wegovy Patient Information Leaflet (and the clinical team at any regulated pharmacy) will direct you to restart at a lower dose to reduce the risk of side effects, rather than pick up at the dose you paused. These are prescription-only medicines, and restarting safely is a clinical decision: a prescriber needs to review your situation before you inject again.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first thing worth establishing is the precise gap. Wegovy is injected once weekly, and the published guidance distinguishes between shorter gaps and those of three weeks or more. If your last dose was exactly three weeks ago, you are at the boundary point where most guidance recommends stepping back rather than resuming. If it has been longer, the case for restarting from a reduced dose is even clearer.
A question our prescribers hear most weeks is whether it matters which day of the week the missed doses fell on. It does, in the sense that counting accurately helps you and your clinician agree on the right restart dose. Pull up your injection diary or pharmacy order history if you are unsure of the date. Knowing whether you are at the three-week mark or closer to four makes a difference to the conversation.
The general Wegovy missed dose guidance on our site covers shorter gaps too, which is useful context for understanding why three weeks sits in its own category.
Semaglutide slows gastric emptying and works partly through pathways your body adapts to gradually during the titration schedule. When you stop for three weeks or more, that adaptation fades. Picking up a 1.7mg or 2.4mg pen as if no time has passed puts a high dose into a system that has effectively reset its tolerance. The result, for many people, is a significant flare of nausea, vomiting, diarrhoea or stomach discomfort — more intense than anything they experienced when first starting.
This is not a theoretical risk. The NHS guidance on semaglutide for weight management notes that the titration schedule exists specifically to minimise gastrointestinal effects, and restarting after a prolonged gap follows the same logic: re-titrate, do not skip steps. The Wegovy SmPC reinforces this at a clinical level. If you want to review your overall Wegovy dose schedule from the beginning, that page walks through the full progression.
There is also a practical point about effectiveness. Weight loss with semaglutide is dose-dependent; re-escalating carefully through the schedule is what gets you back to the dose where you were seeing results, and doing it safely means you are less likely to need to stop again because of side effects.
This is not a step to skip. The exact dose to restart on after a three-week gap is not one-size-fits-all. Someone who was comfortably established on 0.5mg and missed one week of Wegovy before picking back up is in a very different position from someone who has now been without it for far longer. Someone who had just moved up to 1.7mg and found it hard going even before the gap is different again, and our guidance on what to do if you missed 2 weeks of Wegovy explains how that intermediate gap is handled before you reach the three-week threshold. For anyone whose break has stretched to precisely this point, the advice on missing two weeks of Wegovy is also worth reading as background before your prescriber conversation.
Your prescriber will weigh up your previous dose, how well you tolerated it, whether anything has changed in your health or other medicines, and your current weight. They may suggest dropping back a full step, two steps, or in some cases returning to the very beginning of the schedule. That judgement is theirs to make.
If you are already a patient at a regulated online pharmacy and your treatment is in good standing, contacting your prescribing team for a brief review is the right call before you open the next pen. If you are considering moving to a new provider or have not yet started treatment, the free consultation at nume is the place to begin: a GPhC-registered prescriber reviews your answers the same day, not software, and can advise on exactly this kind of situation. You can read more about who we are and how our clinical team works if you want to understand our process first.
Three weeks is long enough to let weekly habits slip. Before you restart, it is worth thinking about what caused the gap. Was it a supply issue, a busy period, side effects that put you off, or something else? The answer shapes what support you might need alongside treatment.
Practically: pick a day of the week and stick to it, set a phone reminder, and store your pens correctly in the fridge between 2°C and 8°C. The standard Wegovy dosing schedule page is a helpful reference for the full titration pathway once your prescriber has confirmed where you are restarting from. For a broader look at how the treatment fits into a structured weight management approach, the weight loss treatments overview covers the landscape.
A longer gap also tends to prompt questions about whether Wegovy is still the right medicine for you, or whether a different approach might suit you better now. Those are entirely reasonable questions to raise at a consultation. Our clinical team profiles, including our lead prescriber, give a sense of who would be reviewing your case.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.